C. R. Bard is the lead sponsor of 9 current clinical trials in our USA, Ireland and China registers. 4 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Arteriovenous Fistula.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, Arteriovenous Fistula
|
Not applicable | Recruiting | 2021-03 | Ireland, USA |
|
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
NCT05945329 · ClinicalTrials.gov ↗ · Capsular Contracture Associated With Breast Implant, Capsular Contracture Grade III, Capsular Contracture Grade IV
|
Not applicable | Recruiting | 2024-12 | USA |
|
Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)
NCT07016698 · ClinicalTrials.gov ↗ · Peripheral Arterial Disease(PAD)
|
Not applicable | Recruiting | 2025-09 | USA |
|
Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension
NCT06669806 · ClinicalTrials.gov ↗ · Portal Hypertension Related to Cirrhosis, Ascites Hepatic, Variceal Bleeding
|
Not applicable | Recruiting | 2024-11 | China |
|
Evaluation of Male and Female External Catheters for Urine Output Monitoring in the ICU
NCT07744945 · ClinicalTrials.gov ↗ · Urine Output, ICU Patients
|
Observational | Not yet open | 2026-08 | USA |
|
Venclose digiRF System Post Market Study
NCT05504070 · Venous Reflux, Chronic Venous Insufficiency
|
Not applicable | Active, closed | 2023-09 | USA |
|
Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae
NCT03506308 · Arteriovenous Fistula
|
Not applicable | Active, closed | 2018-08 | USA |
|
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
NCT03911700 · ClinicalTrials.gov ↗ · Open Midline Laparotomy
|
Not applicable | Active, closed | 2019-12 | USA |
|
The BD Liverty™ TIPS Stent Graft Study
NCT05711316 · ClinicalTrials.gov ↗ · Portal Hypertension, TIPS
|
Not applicable | Active, closed | 2023-08 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 8 | 3 |
| Clinical trials in Ireland | 1 | 1 |
| Clinical trials in China | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
C. R. Bard is the lead sponsor of 9 current trials on ClinicalTrials.gov in our USA, Ireland and China registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 4 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.